Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report
- PMID:15301690
- PMCID: PMC514562
- DOI: 10.1186/1472-6904-4-6
Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report
Abstract
Background: Intrathecal baclofen pump has been used effectively with increasing frequency in patients with severe spasticity, particularly for those patients who are unresponsive to conservative pharmacotherapy or develop intolerable side effects at therapeutic doses of oral baclofen. Drowsiness, nausea, headache, muscle weakness, light-headedness and return of pretreatment spasticity can be caused by intrathecal pump delivering an incorrect dose of baclofen. Intrathecal baclofen withdrawal syndrome is a very rare, potentially life-threatening complication of baclofen pump caused by an abrupt cessation of intrathecal baclofen.
Case presentation: A 24-year-old man with a past medical history of cerebral palsy and spastic quadriparesis developed hyperthermia, disseminated intravascular coagulation, rhabdomyolysis, acute renal failure and multisystem organ failure leading to a full-blown intrathecal baclofen withdrawal syndrome. Intrathecal baclofen pump analysis revealed that it was stopped due to some programming error. He was treated effectively with supportive care, high-dose benzodiazepines and reinstitution of baclofen pump.
Conclusion: The episodes of intrathecal baclofen withdrawal syndrome are mostly caused by preventable human errors or pump malfunction. Educating patients and their caregivers about the syndrome, and regular check-up of baclofen pump may decrease the incidence of intrathecal baclofen withdrawal syndrome. Oral baclofen replacement may not be an effective method to treat or prevent intrathecal baclofen withdrawal syndrome. Management includes an early recognition of syndrome, proper intensive care management, high-dose benzodiazepines and prompt analysis of intrathecal pump with reinstitution of baclofen.
Similar articles
- Intrathecal baclofen withdrawal: a case report and review of the literature.Alden TD, Lytle RA, Park TS, Noetzel MJ, Ojemann JG.Alden TD, et al.Childs Nerv Syst. 2002 Oct;18(9-10):522-5. doi: 10.1007/s00381-002-0634-8. Epub 2002 Jul 23.Childs Nerv Syst. 2002.PMID:12382179Review.
- Intrathecal baclofen withdrawal resembling serotonin syndrome in an adolescent boy with cerebral palsy.Salazar ML, Eiland LS.Salazar ML, et al.Pediatr Emerg Care. 2008 Oct;24(10):691-3. doi: 10.1097/PEC.0b013e318188a952.Pediatr Emerg Care. 2008.PMID:19240673
- Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report.Hansen CR, Gooch JL, Such-Neibar T.Hansen CR, et al.Arch Phys Med Rehabil. 2007 Nov;88(11):1468-71. doi: 10.1016/j.apmr.2007.07.021.Arch Phys Med Rehabil. 2007.PMID:17964889
- Intrathecal baclofen overdose and withdrawal.Shirley KW, Kothare S, Piatt JH Jr, Adirim TA.Shirley KW, et al.Pediatr Emerg Care. 2006 Apr;22(4):258-61. doi: 10.1097/01.pec.0000210175.40763.c5.Pediatr Emerg Care. 2006.PMID:16651918
- Management of acute overdose or withdrawal state in intrathecal baclofen therapy.Watve SV, Sivan M, Raza WA, Jamil FF.Watve SV, et al.Spinal Cord. 2012 Feb;50(2):107-11. doi: 10.1038/sc.2011.112. Epub 2011 Oct 18.Spinal Cord. 2012.PMID:22006082Review.
Cited by
- Stability Study of Baclofen in an Oral Powder Form Compounded for Pediatric Patients in Japan.Saito J, Hanawa T, Ozawa A, Matsumoto T, Yoshikawa N, Harada T, Iwahashi K, Yamatani A.Saito J, et al.Children (Basel). 2022 Aug 29;9(9):1313. doi: 10.3390/children9091313.Children (Basel). 2022.PMID:36138622Free PMC article.
- A critical review of the pathophysiology of dysautonomia following traumatic brain injury.Baguley IJ, Heriseanu RE, Cameron ID, Nott MT, Slewa-Younan S.Baguley IJ, et al.Neurocrit Care. 2008;8(2):293-300. doi: 10.1007/s12028-007-9021-3.Neurocrit Care. 2008.PMID:17968518Review.
- Acute intrathecal baclofen withdrawal: a brief review of treatment options.Ross JC, Cook AM, Stewart GL, Fahy BG.Ross JC, et al.Neurocrit Care. 2011 Feb;14(1):103-8. doi: 10.1007/s12028-010-9422-6.Neurocrit Care. 2011.PMID:20717751Review.
- Clinical Management of Dystonia in Childhood.Luc QN, Querubin J.Luc QN, et al.Paediatr Drugs. 2017 Oct;19(5):447-461. doi: 10.1007/s40272-017-0243-3.Paediatr Drugs. 2017.PMID:28620849Review.
- Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting.Gburek-Augustat J, Krause M, Bernhard M, Sorge I, Gräfe D, Siekmeyer M, Nestler U, Merkenschlager A.Gburek-Augustat J, et al.Childs Nerv Syst. 2021 Aug;37(8):2597-2604. doi: 10.1007/s00381-021-05154-3. Epub 2021 Apr 8.Childs Nerv Syst. 2021.PMID:33834279Free PMC article.
References
- Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B, Smith R, Wilberger J, Loeser JD, Chabal C, Feler C, Robertson JT, Renn RD, Clarke A, Burchiel KJ, Leibrock LG. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993;78:226–232. - PubMed
- Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236–240. - PubMed
- Van SP, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery. 2000;46:603–609. - PubMed
- Penn RD, York MM, Paice JA. Catheter systems for intrathecal drug delivery. J Neurosurg. 1995;83:215–217. - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous